Comment by AnthonyMouse
Comment by AnthonyMouse 12 hours ago
It's about the dichotomy. If the NY Times has First Amendment rights then Pfizer does.
That annoys people because Pfizer is going to advocate for things some people might not like. But that's the cost of a rule that makes it so the NY Times can advocate for things other people might not like.
It's still possible to grant press organisations rights that other corporations don't get without having to make both of them people.